21.73
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Q1 Rundown: Elanco (NYSE:ELAN) Vs Other Pharmaceuticals Stocks - Yahoo Finance
Elanco Launches Befrena As New Dermatology Driver For Undervalued Shares - Yahoo Finance
Companion Animal Health Market is expected to Hit US$ 56.60 - openPR.com
Is Elanco Animal Health Inc (ELAN) Overvalued After 5.3% Rally? - GuruFocus
Elanco EVP Rajeev Modi buys $99,938 of company stock By Investing.com - Investing.com Nigeria
Elanco CEO Jeffrey Simmons buys $99,842 in company stock By Investing.com - Investing.com Nigeria
Elanco CEO Jeffrey Simmons buys $99,842 in company stock - Investing.com
Elanco EVP Rajeev Modi buys $99,938 of company stock - Investing.com
Elanco (NYSE: ELAN) officer Modi buys shares and receives deferred stock units - Stock Titan
Elanco (NYSE: ELAN) CEO adds shares and receives deferred units - Stock Titan
Elanco (NYSE: ELAN) CFO receives grant of deferred stock units as compensation - Stock Titan
Elanco Animal Health Launches Canine Dermatitis Drug Befrena - Moomoo
Elanco Animal Health (ELAN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Elanco Animal Health’s SWOT analysis: stock outlook amid growth targets - Investing.com India
Elanco Animal Health’s SWOT analysis: stock outlook amid growth targets By Investing.com - Investing.com Nigeria
Elanco (ELAN) Launches New Canine Allergy Treatment Befrena - GuruFocus
Elanco launches canine dermatitis treatment Befrena in U.S. By Investing.com - Investing.com Canada
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market - PR Newswire
Elanco Animal Health (ELAN) Stock Report: A Healthcare Stock with Nearly 50% Upside Potential - DirectorsTalk Interviews
Elanco Q1 2026 Earnings: Revenue $1.37B, EPS $0.40, Guidance RaisedNews and Statistics - IndexBox
5 Insightful Analyst Questions From Elanco’s Q1 Earnings Call - Yahoo Finance
Elanco Animal Health Inc (ELAN) Shares Fall 8.2% -- What GF Scor - GuruFocus
Elanco Animal Health Inc (ELAN) Shares Fall 8.2% -- What GF Score of 70 Tells Investors - GuruFocus
Elanco finalizes acquisition of AHV International - Feed Strategy
Morgan Stanley Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Raises Target Price to $23 - Moomoo
Elanco to Participate in Investor Conferences - Intellectia AI
Elanco to Participate in Upcoming Investor Conferences - GuruFocus
Dodge & Cox holds 13.9% of Elanco (NYSE: ELAN) in 13G/A amendment - Stock Titan
How to listen in as Elanco execs talk to investors in May and June - Stock Titan
Elanco reaches $9.3M settlement with consumers over antitrust allegations involving flea and tick products - Indianapolis Business Journal
Elanco to pay $6.75M to settle antitrust allegations involving flea and tick products - Inside INdiana Business
Primecap Management reports 9.22% stake in Elanco (ELAN) - Stock Titan
Elanco On Hook For Bulk Of $9M Flea & Tick Meds Deal - Law360
Earnings call transcript: Elanco Q1 2026 beats forecasts with strong growth - Investing.com Canada
Pet Wellness Products Market Touching New Development Level | Zoetis, Elanco, Virbac - openPR.com
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Elanco Animal Health (ELAN) and Align Tech (ALGN) - The Globe and Mail
Elanco Animal Health Inc (ELAN) Shares Fall 8.2% -- GF Value Says Still Overvalued - GuruFocus
Elanco (ELAN) Q1 earnings: What to expect - MSN
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - TMX Newsfile
Elanco Animal Health Q1 Earnings Call Highlights - MarketBeat
Q1 2026 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Q3 2025 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Elanco Animal Health Inc Investor Day Transcript - GuruFocus
ELAN SEC FilingsElanco Animal Health 10-K, 10-Q, 8-K Forms - Stock Titan
Elanco (ELAN) shares climb after strong quarterly results and higher full-year outlook - msn.com
MSN Money - MSN
Elanco Animal Health Price Target Raised to $31.00/Share From $30.00 by Citigroup - Moomoo
Elanco Animal Health 1Q Adj EPS 40c >ELAN - Moomoo
ELAN Maintained by Citigroup -- Price Target Raised to $31.00 - GuruFocus
ELAN Maintained by JP Morgan -- Price Target Raised to $30 - GuruFocus
Elanco Earnings Call Highlights Innovation-Led Growth - The Globe and Mail
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):